• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Autologous reconstitution with BCR-ABL-negative haematopoiesis after T cell-depleted allogeneic BMT for CML.

作者信息

Serrano J, Román J, Castillejo J A, Sánchez J, Navarro J A, Martín C, Herrera C, Torres A

机构信息

Haematology Department, University Hospital Reina Sofía, Córdoba, Spain.

出版信息

Bone Marrow Transplant. 1998 Sep;22(6):599-601. doi: 10.1038/sj.bmt.1701379.

DOI:10.1038/sj.bmt.1701379
PMID:9758352
Abstract

We report a patient with Ph chromosome-positive CML who underwent an HLA-identical T cell-depleted BMT from a sibling donor. DNA polymorphism analysis showed complete donor chimaerism after BMT, followed by mixed chimaerism of granulocytes, natural killer cells and B lymphocytes, with T lymphocytes host-derived at day +120 post BMT. From month +20 haematopoiesis was exclusively of host origin in all cell lineages. RT-PCR was used in order to detect residual disease, but at the time, analysis did not show BCR-ABL transcripts. This case is unusual in that non-malignant stem cells of recipient origin survived the transplant and reconstituted haematopoiesis after BMT. Two years post transplant, no molecular or haematological relapse was documented. The observation that subsequent recipient recovery without molecular relapse implies that, at least in this case, the GVL effect can occur in the absence of donor T cells.

摘要

相似文献

1
Autologous reconstitution with BCR-ABL-negative haematopoiesis after T cell-depleted allogeneic BMT for CML.
Bone Marrow Transplant. 1998 Sep;22(6):599-601. doi: 10.1038/sj.bmt.1701379.
2
Reconstitution with Philadelphia chromosome-negative recipient haematopoiesis early after allogeneic BMT for CML.
Bone Marrow Transplant. 1996 Mar;17(3):453-5.
3
Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.聚合酶链反应对于慢性粒细胞白血病患者接受T细胞去除的异基因骨髓移植后的复发具有高度预测性。
Bone Marrow Transplant. 1996 Apr;17(4):643-7.
4
Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.异基因骨髓移植后混合嵌合体与白血病复发相关的定性评估。
Cancer Detect Prev. 1996;20(6):601-9.
5
Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia.持续的供体嵌合现象与慢性髓性白血病骨髓移植后的无病生存一致。
Bone Marrow Transplant. 1997 Aug;20(3):235-41. doi: 10.1038/sj.bmt.1700861.
6
Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.微小残留病的检测及宿主型造血的持续存在:一项针对28例费城染色体阳性慢性髓性白血病患者接受性别不匹配、非T细胞去除的异基因骨髓移植后的研究。
Bone Marrow Transplant. 1995 Dec;16(6):823-9.
7
Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.在慢性粒细胞白血病患者接受非处理的异基因骨髓移植后,髓系混合嵌合现象与bcr-abl阳性患者的复发相关。
Haematologica. 2000 Feb;85(2):173-80.
8
Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.慢性髓性白血病异基因骨髓移植后短暂细胞遗传学复发的分子分析
Bone Marrow Transplant. 1996 Dec;18(6):1147-52.
9
Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.供体嵌合现象是慢性粒细胞白血病患者骨髓移植后无病生存的一个重要指标。
Leukemia. 1997 Apr;11 Suppl 3:512-5.
10
Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results.慢性粒细胞白血病骨髓移植后的微小残留病及其对移植物抗白血病效应的影响:近期结果综述
Bone Marrow Transplant. 1994 Aug;14(2):201-9.

引用本文的文献

1
Successful eradication of chronic myeloid leukemia in a child despite allogeneic graft rejection.尽管异体移植物排斥,一名儿童的慢性髓性白血病仍被成功治愈。
Cancer Rep (Hoboken). 2022 Oct;5(10):e1663. doi: 10.1002/cnr2.1663. Epub 2022 Jul 7.
2
Autologous Hematopoietic Recovery after Unrelated Umbilical Cord Blood Transplantation with Myeloablative Conditioning for Acute Myelogenous Leukemia.异基因脐带血造血干细胞移植预处理方案对急性髓系白血病患者的造血重建影响
Intern Med. 2020 Oct 1;59(19):2409-2414. doi: 10.2169/internalmedicine.4829-20. Epub 2020 Jun 15.
3
Autologous reconstitution leading to sustained JAK2-V617F negativity post allogeneic hematopoietic stem cell transplant in JAK2-V617F positive myelofibrosis.
在JAK2-V617F阳性骨髓纤维化患者中,异基因造血干细胞移植后自体造血重建导致JAK2-V617F持续阴性。
Bone Marrow Transplant. 2015 Nov;50(11):1480-2. doi: 10.1038/bmt.2015.169. Epub 2015 Jul 27.